Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
1. Primary Aim: To evaluate the efficacy of atomoxetine in reducing the frequency of primary nocturnal enuresis episodes in children with ADHD. 2. Secondary Aim: To determine if improvements in attention symptoms correlate with reductions in nocturnal enuresis episodes.
Epistemonikos ID: f04c85238ff1d50e219042e928cfc9a94741097f
First added on: Mar 01, 2025